Zelta by Merative

We’re excited to announce that Zelta has been positioned as a Major Contender in the Everest Group 2024 Life Sciences Clinical Data and Analytics Platforms PEAK Matrix® Assessment! As an #EDC and CDMS solutions provider, this new recognition is gratifying. We don’t believe that EDCs need to be huge, robust, and frankly overwhelming data and analytics platforms. More isn’t necessarily better; when it comes to #clinicaldatamanagement, “more” quickly becomes “too much.” Check out our new blog outlining our philosophy on data, analytics, and reporting in #clinicaltrials, and why Zelta takes a more focused, user-friendly approach for greater control and confidence in the data and analytics experience. https://lnkd.in/drSJs38C

With Zelta, Integrated Therapeutic Solutions Inc. has been able to build databases for their clients that are cleaner, faster, and more efficient – with less time spent on monitoring and #datamanagement, and cleaner data to work with. Learn more about how Zelta enables #CROs like Integrated Therapeutics to design cleaner databases that provide cleaner data outputs. https://lnkd.in/eSrXxNDs

Large language models (LLMs) such as ChatGPT are frequently hailed as revolutionary tools for any workplace. However, in the pharma industry, smaller-scale supervised machine learning models could provide more effective and reliable solutions. Learn more in the article from Zelta by Merative - https://lnkd.in/geqU-hga Explore more from the report: https://lnkd.in/gXwv3Y3c #clinicaltrials #LLMs #pharma #machinelearning

It is common for sponsors to switch digital platforms between clinical trial phases. However, sponsors can achieve greater efficiencies by identifying a nimble platform, which can support all trial phases and reduce study complexity. Learn more in this article from Zelta by Merative - https://lnkd.in/ghA6YDC2   #clinicaltrials #clinicalresearch #pharma

Vogenx, Inc has been using Zelta as their #EDC solution for two studies trialing a drug that doesn’t exist yet on the market, and whose absence has been filled by patients using off-label solutions and dietary workarounds that are minimally effective at best. Check out Vogenx’s story on how they built a study with a tricky drug randomization component from scratch with Zelta. https://lnkd.in/eSrXxNDs

Why did Everest Group rank Zelta as a Leader in its Life Sciences EDC Products PEAK Matrix® Assessment 2024? • Highly configurable, easy-to-use, low-code solution • #EDC integration capabilities like CTMS, RTSM, and IRTs • Expansive partnership ecosystem with #CTMS, #RTSM, clinical supplier providers, service providers, healthcare payers, providers, and payment technology providers • Modular offerings, competitive pricing, and a client-centric approach to active support, project management, and query resolution Get the full rundown on Zelta’s Leader ranking and why our industry-leading EDC platform is ideal for #CROs and #sponsors to build and manage their #clinicaltrial studies. https://lnkd.in/egs5FsPz

With the boom in eClinical solutions showing no signs of slowing, adding a “human at the center” perspective can help optimize data management functions and empower organizations to build self-sufficiency. Learn more in this article from Zelta by Merative - https://lnkd.in/dzdAnDG8 #clinicaltrials #eclinical #clinicaldata #clinicaldatamanagement

For Alira Health, building their first clinical study on Zelta was relatively simple compared to other platforms they tried. Building the study from a reusable template meant that the Alira team didn’t need to recreate activities like roles, subject and page statuses, and query types each time – all of which adds up to major time savings for new study builds. Learn more about how Zelta’s time savings and quick user support have made building #clinicalstudies faster and easier for Alira Health, and how platform capabilities like #locallabs support and automatic edit checks are helping to alleviate even more time-consuming tasks. https://lnkd.in/eSrXxNDs

#GenerativeAI is dominating the AI conversation right now, and its possibilities for #clinicaltrial studies are very intriguing. Zelta has been working for over a decade to help trial teams build, execute, and accelerate clinical trials with greater control and confidence – and AI is central to our strategy and vision for doing that. But our approach is driven by use cases, not tech. That’s why we’re focused on more targeted, value-adding deployments: scalable, supervised #machinelearning models, purpose built directly within our eClinical platform. Read the new whitepaper by Walker Bradham and DJ McCloskey to see how our purpose-built, supervised ML approach contrasts with Gen AI. How we evaluated all of these options to best solve the challenges facing Zelta users. And our track record for the past decade in leveraging automation and supervised ML to help our clients achieve measurable ROI. What are your AI ambitions? Is your organization looking at machine learning? GenAI? Or something else altogether? Let us know in the comments! https://lnkd.in/enzkyGA8

#ClinicalTrials rely heavily on effective data management for accuracy and integrity in research findings. After all, better #datamanagement outcomes ultimately benefit the patient. But achieving those data management outcomes requires #CROs and #sponsors to deploy a best-in-class approach that holistically combines market-leading solutions with the right environment for people to succeed in. Check out the latest from Jennifer Duff on five best-in-class technology approaches that do exactly this, from leveraging #eConsent for higher efficiency to applying #AI and #MachineLearning in clinical research. https://lnkd.in/ePd8s4zm